Jean‐Marc Léger - Concepedia

Author

Jean‐Marc Léger

Sorbonne Université

Also Known As

Jean-Marc Leger, Jean-Marc Léger, Jean-Marc Léger, Jean‐Marc Leger, Jean‐Marc Léger, Karine Viala

126

Publications

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Pitié-Salpêtrière Hospital Assistance Publique – Hôpitaux de Paris Hôpital de la Timone Maastricht University

About

Jean‐Marc Léger is an author at Sorbonne Université specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	861
2	Health Sciences	4	4	160
3	Engineering	1	1	166
4	Social Sciences	1	1	32
5	Chemistry	1	1	166

Jean‐Marc Léger

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Peripheral Nerve Society Guideline* on the classification, diagnosis, investigation, and immunosuppressive therapy of non‐systemic vasculitic neuropathy: executive summary Michael P. Collins, P. James B. Dyck, Gary Gronseth, Journal of the Peripheral Nervous System	2010	275
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey Benjamin Terrier, Evguenia Krastinova, I. Marie, Blood	2012	234
The Spectrum of Type I Cryoglobulinemia Vasculitis Benjamin Terrier, Alexandre Karras, Jean‐Emmanuel Kahn, Medicine Unknown SignificanceVasculitisImmunologyPathologyImmunotherapy	2013	199
Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy Jean‐Marc Léger, Karine Viala, Guillaume Nicolas, Neurology	2013	198
Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy Guillaume Nicolas, Thierry Maisonobe, Nadine Le Forestier, Muscle & Nerve	2001	169
Amphibole compositional trends in oversaturated and undersaturated alkaline plutonic ring-composition André Giret, Bernard Bonin, Jean‐Marc Léger The Canadian Mineralogist Materials ScienceInorganic ChemistryAmphibole Compositional TrendsEngineeringOrganic Chemistry	1980	166
A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy Karine Viala, Thierry Maisonobe, Tanya Stojkovic, Journal of the Peripheral Nervous System Supportive CriteriaChronic InflammatoryNeurological DisorderPeripheral Nerve InjuryPathology	2010	161
Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features Juliette Svahn, Philippe Petiot, Jean‐Christophe Antoine, Journal of Neurology Neurosurgery & Psychiatry	2017	103
Sensory chronic inflammatory demyelinating polyneuropathy: An under-recognized entity? Xavier Ayrignac, Karine Viala, R.M. Koutlidis, Muscle & Nerve	2013	79
Efficacy and safety of Privigen<sup>®</sup> in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase <scp>III</scp> study (the <scp>PRIMA</scp> study) Jean‐Marc Léger, Jan De Bleecker, Claudia Sommer, Journal of the Peripheral Nervous System Chronic InflammatoryImmunodeficienciesClinical NeurologyNeurological ProgressPharmacotherapy	2013	75

Page 1